Ligand ID: BJM Drugbank ID: DB06335(Saxagliptin) Indication:Treatment of type 2 diabetes mellitus to improve glycemic control in combination with other agents or as monotherapy. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298TYR A 118VAL A 114TYR A 126VAL A 125 | 1.78A | 16.43 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ARG C 285GLU C 264SER C 116VAL C 166TYR C 265 | 1.62A | 17.31 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ARG C 285GLU C 264SER C 116VAL C 166TYR C 265 | 1.62A | 17.31 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.71A | 16.43 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | ARG B 298PHE B 291SER B 113VAL B 114ASN B 151 | 1.76A | 16.62 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | ARG B 298PHE B 291SER B 113VAL B 114ASN B 151 | 1.66A | 15.90 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.67A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 2z9l | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.60A | 16.43 | DMS A 605 (-4.0A)NoneNoneNoneNone | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298TYR A 118VAL A 114TYR A 126VAL A 125 | 1.77A | 16.43 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298TYR A 118VAL A 114TYR A 126VAL A 125 | 1.76A | 16.43 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.79A | 16.11 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298PHE B 291SER B 113VAL B 114ASN B 151 | 1.65A | 16.00 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 3e9s | NSP3 (SARSr-CoV) | 5 / 12 | ARG A 285GLU A 264SER A 116VAL A 166TYR A 265 | 1.76A | 17.54 | NoneNoneOCS A 112 ( 3.7A)NoneTTT A 317 (-4.1A) | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.67A | 15.81 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298PHE B 291SER B 113VAL B 114ASN B 151 | 1.54A | 16.05 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.75A | 16.20 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 298PHE B 291SER B 113VAL B 114ASN B 151 | 1.72A | 16.29 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.69A | 15.62 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 3to2 | MHC CLASS I ANTIGEN (Homosapiens) | 5 / 12 | TYR A 85TYR A 84TYR A 116TYR A 123VAL A 95 | 1.77A | 18.15 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.75A | 16.33 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 5 / 12 | ARG B 139GLU B 135TYR B 84VAL B 12ASN B 14 | 1.80A | 17.43 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLU D 239TYR D 214TYR D 311VAL D 236VAL D 185 | 1.71A | 17.31 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.78A | 11.89 | DMS A 402 (-3.7A)NoneDMS A 402 ( 4.7A)NoneNone | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ARG D 139GLU D 135TYR D 84VAL D 12TYR D 72 | 1.59A | 17.31 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ARG D 139GLU D 135TYR D 84VAL D 12TYR D 72 | 1.63A | 17.31 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | ARG C1057PHE C 814SER B 607VAL B 375ASN B 436 | 1.79A | 21.20 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ARG C 183GLU C 93VAL C 140ASN C 96VAL C 172 | 1.80A | 21.34 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ARG B 183GLU B 93VAL B 140ASN B 96VAL B 172 | 1.73A | 21.26 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ARG B 183GLU B 93VAL B 140ASN B 96VAL B 172 | 1.71A | 21.26 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLU C 553PHE C 546VAL C 589TYR C 488VAL C 586 | 1.69A | 20.78 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG D 298TYR B 118VAL B 114TYR B 126VAL B 125 | 1.78A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG D 298TYR B 118VAL B 114TYR B 126VAL B 125 | 1.78A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG D 298PHE D 291SER D 113VAL D 114ASN D 151 | 1.76A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.57A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.18A | 20.10 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.47A | 20.52 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.70A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6y2e | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.56A | 16.14 | None | ||
![]() | 3BJM_A_BJMA1_1 (DIPEPTIDYL PEPTIDASE4) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ARG B 298TYR A 118VAL A 114TYR A 126VAL A 125 | 1.77A | 16.14 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ARG A 298PHE A 291SER A 113VAL A 114ASN A 151 | 1.77A | 11.89 | DMS A 403 (-3.9A)NoneDMS A 403 ( 4.9A)NoneNone | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.45A | 20.10 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.12A | 20.16 | None | ||
![]() | 3BJM_B_BJMB2_1 (DIPEPTIDYL PEPTIDASE4) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | ARG A 654GLU A 658PHE A 348VAL A 560ASN A 568 | 1.19A | 20.16 | NoneNoneNone U T 10 ( 4.6A)None |